drugset / Trial / NCT04410354
Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of merimepodib (MMPD) oral solution when administered in combination with remdesivir in adult patients with advanced COVID-19.
Timeline
- Start
- 2020-06-16
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
Outcome
Outcome not reported
Stopped: “Failure to meet primary endpoint”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Merimepodib | Small molecule | 400 mg | Oral |
| Comparator | Remdesivir | Small molecule | 100 mg | Intravenous |